Mark Hazeltine - Net Worth and Insider Trading

Mark Hazeltine Net Worth

The estimated net worth of Mark Hazeltine is at least $175,541 dollars as of 2024-05-21. Mark Hazeltine is the Chief Business Officer of Exagen Inc and owns about 93,872 shares of Exagen Inc (XGN) stock worth over $175,541. Details can be seen in Mark Hazeltine's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Hazeltine has not made any transactions after 2023-02-08 and currently still holds the listed stock(s).

Transaction Summary of Mark Hazeltine

To

Mark Hazeltine Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Hazeltine owns 1 companies in total, including Exagen Inc (XGN) .

Click here to see the complete history of Mark Hazeltine’s form 4 insider trades.

Insider Ownership Summary of Mark Hazeltine

Ticker Comapny Transaction Date Type of Owner
XGN Exagen Inc 2023-02-08 Chief Operating Officer

Mark Hazeltine Latest Holdings Summary

Mark Hazeltine currently owns a total of 1 stock. Mark Hazeltine owns 93,872 shares of Exagen Inc (XGN) as of February 8, 2023, with a value of $175,541.

Latest Holdings of Mark Hazeltine

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XGN Exagen Inc 2023-02-08 93,872 1.87 175,541

Holding Weightings of Mark Hazeltine


Mark Hazeltine Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Hazeltine has made a total of 1 transactions in Exagen Inc (XGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Exagen Inc is the sale of 5,821 shares on February 8, 2023, which brought Mark Hazeltine around $15,659.

Insider Trading History of Mark Hazeltine

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Hazeltine Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Hazeltine Ownership Network

Ownership Network List of Mark Hazeltine

No Data

Ownership Network Relation of Mark Hazeltine


Mark Hazeltine Owned Company Details

What does Exagen Inc do?

Who are the key executives at Exagen Inc?

Mark Hazeltine is the Chief Operating Officer of Exagen Inc. Other key executives at Exagen Inc include director & President and CEO John Aballi , Chief Financial Officer Kamal Adawi , and 10 percent owner Tullis Growth Fund Ii, L.p. .

Exagen Inc (XGN) Insider Trades Summary

Over the past 18 months, Mark Hazeltine made 1 insider transaction in Exagen Inc (XGN) with a net sale of 5,821. Other recent insider transactions involving Exagen Inc (XGN) include a net purchase of 96,582 shares made by John Aballi , a net sale of 25,343 shares made by Kamal Adawi , and a net purchase of 167 shares made by Tullis Growth Fund Ii, L.p. .

In summary, during the past 3 months, insiders sold 12,784 shares of Exagen Inc (XGN) in total and bought 40,401 shares, with a net purchase of 27,617 shares. During the past 18 months, 64,983 shares of Exagen Inc (XGN) were sold and 130,568 shares were bought by its insiders, resulting in a net purchase of 65,585 shares.

Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Exagen Inc Insider Transactions

No Available Data

Mark Hazeltine Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Hazeltine. You might contact Mark Hazeltine via mailing address: C/o Exagen Inc., 1261 Liberty Way, Suite C, Vista Ca 92081.

Discussions on Mark Hazeltine

No discussions yet.